Skip to main content
. 2024 Mar 4;24:96. doi: 10.1186/s12876-024-03164-4

Table 1.

Baseline characteristics of study participants in relation to the presence of Non-alcoholic fatty liver disease (N = 181)

Variable Frequency (%) or median (IQR) P value
All patients (n = 181) NAFLD present (n = 55) NAFLD absent (n = 126)
Sex 0.57
 Male 54 (29.8) 18 (32.7) 36 (28.6)
 Female 127 (70.2) 37 (67.3) 90 (71.4)
Age (years): < 30 1 (0.5) 1 (1.8) 0 α
 30–40 16 (8.8) 3 (5.4) 13 (10.3) 0.29
 41–50 30 (16.5) 6 (10.9) 24 (19.0) 0.18
 51–60 55 (30.4) 20 (36.3) 35 (27.8) 0.25
 61–70 58 (32.0) 21 (38.2) 37 (29.4) 0.24
  > 70 21 (11.6) 4 (7.3) 17 (13.5) 0.23
BMI (kg/m2): Overweight (25–29.9) 31 (17.1) 6 (10.9) 25 (19.8) 0.14
 Obesity class I (30 to 34.9) 76 (41.9) 18 (32.7) 58 (46.0) 0.09
 Obesity class II (35–39.9) 50 (27.6) 19 (34.6) 31 (24.6) 0.17
 Obesity class III (≥40) 24 (13.3) 12 (21.8) 12 (9.5) 0.03
Residence 0.12
 Urban 93 (52.4) 33 (60.0) 60 (47.6)
 Rural 88 (48.6) 22 (40.0) 66 (52.4)
Underlying condition
 Hypertension 131 (72.4) 44 (80.0) 87 (69.0) 0.13
 Diabetes Mellitus 80 (44.2) 30 (54.5) 50 (39.7) 0.06
 Hypertension and diabetes mellitus 74 (40.9) 28 (50.9) 46 (36.5) 0.07
Systolic blood pressure (mmHg) 134 (122–146) 141 (126–153) 13 3 (121–143) 0.05
Diastolic blood pressure (mmHg) 83 (73–89) 86 (74–90) 81.5 (72.0–88.0) 0.16
Waist circumference (cm) 103.5 (98–113.5) 109 (99–121) 102 (97–112) 0.006
Triglycerides (mg/dl) 1.4 (1.0–1.9) 1.9 (1.2–2.3) 1.2 (0.9–1.6) < 0.001
High-density lipoproteins (mmol/L) 1.1 (0.9–1.4) 1.0 (0.8–1.3) 1.1 (0.9–1.4) 0.03
Fasting blood glucose (mmol/L) 5.8 (5.2–6.8) 6.4 (5.6–7.9) 5.6 (5.2–6.3) < 0.001
Uric acid (μmol/L) 381.4 (310.6–447.8) 426 (335.7–532.0) 372.4 (295.8–423.1) < 0.001
Triglyceride-glucose index 8.8 (8.4–9.2) 9.2 (8.8–9.5) 8.6 (8.4–8.9) < 0.001
Triglyceride-glucose index-BMI 293.4 (268.6–324.7) 320.2 (289.1–354.6) 286.4 (266.1–312.3) < 0.001

IQR Interquartile range, NAFLD Non-alcoholic fatty liver disease, BMI Body mass index

α Not computed because of zero observation